HEMISPHERX BIOPHARMA INC·4

Mar 1, 11:59 AM ET

Pascale Adam 4

4 · HEMISPHERX BIOPHARMA INC · Filed Mar 1, 2018

Insider Transaction Report

Form 4
Period: 2018-02-13
Pascale Adam
Chief Accounting Officer
Transactions
  • Award

    Options to buy Common Stock

    2018-02-13+123,874123,874 total
    Exercise: $0.37From: 2018-02-13Exp: 2028-02-13Common Stock (123,874 underlying)
Footnotes (1)
  • [F1]This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT